Navigation Links
IdentiGEN's DNA TraceBack(R) Receives USDA Process Verified Program Approval
Date:11/5/2007

World's First DNA-based Meat Traceability System Introduced in U.S.

LAWRENCE, Kan., and DUBLIN, Ireland, Nov. 5 /PRNewswire/ -- IdentiGEN's DNA TraceBack(R) system, a proprietary meat identification and traceability system based on DNA analysis, has been approved by the United States Department of Agriculture's (USDA) Agricultural Marketing Service as a Process Verified Program (PVP). The DNA TraceBack system enables retailers, meat producers, meat processors and food-service outlets to respond to the growing consumer demand, both domestically and in export markets, for more information about where and how their meat is produced.

IdentiGEN is a leading global provider of DNA-based identification and verification solutions for enhancing food safety and building consumer confidence in the food and agriculture industries. DNA TraceBack utilizes DNA identification technology -- in a manner akin to that used for forensic investigations -- to identify and trace the source of meat products through the entire supply chain.

The DNA TraceBack system uses IdentiGEN's proprietary ID-GENerator(TM)technology to create large numbers of unique DNA profiles at a cost of pennies per pound. Its implementation requires few modifications to current handling and processing procedures for fresh beef and pork.

"Considering that DNA TraceBack is just being introduced in the North American market, designation as a PVP is a significant milestone for IdentiGEN," said Donald R. Marvin, president and CEO of IdentiGEN North America. "This vote of confidence from the USDA in our DNA TraceBack system will help gain acceptance of the program among grocery retailers, and ultimately, consumers."

IdentiGEN's DNA TraceBack system was approved as a PVP after an extensive review and on-site audit of IdentiGEN's documented quality-management system by USDA auditors. PVP designation signifies that the USDA has verified IdentiGEN's DNA TraceBack system as a consistently
'/>"/>

SOURCE IdentiGEN, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...IGNA HealthCare of Arizona and Catholic,Healthcare...ely, CIGNA plan,members will have in-network acces...althcare West facilities and providers. The contra... hospitals, including St. Joseph,s,Hospital and Me...rcy,Gilbert Medical Center, and affiliated facilit...
(Date:5/9/2008)...re-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFA...rsing,services, today announced that the underwrit...llotment option in part and purchased 262,500,addi...ng price of $17.75,per share. Including the over-a... offering for net proceeds of $41.8 million, after...
(Date:5/9/2008)... those who take up the habit , , FRIDAY,...udents to spread anti-smoking messages in their ev...ng rates, according to a U.K. study. , The s...3, at 59 schools in western England and Wales. At ...to receive training about the risks of smoking, th...
(Date:5/9/2008)...ma, depression and many other diseases, researcher... -- A new class of drugs called vaptans may be abl...painful periods, brain hemorrhage, psychotic disor..., Vaptans, short for vasopressin-receptor antagoni...tem, which plays an important role in controlling ...
Breaking Medicine News(10 mins):Health News:CIGNA HealthCare of Arizona and Catholic Healthcare West Reach Agreement 2Health News:Almost Family, Inc. Announces Exercise of Over-Allotment Option 2Health News:Training Student Leaders Cuts Peers' Smoking Rates 2Health News:New Class of Drugs Might Treat Many Conditions 2
...emed to decrease the risk to develop rheumatoid ar....The results of the research has been documented i...of Sciences. . Rheumatic arthritis is the result o...o which the immune system is triggered to fight th...
...igrate to the industrialized regions in India's we...AIDS.// Bihari migrants are estimated to range fro... as taxi drivers, mechanics, security guards or do... "I just did not think about what I was doing," S...
...echnology firm, is keen to invest $400 million pro...s equipment for a global market.// Anita Goel, fou...bmitted the project proposal to Chief Minister Vir...nd. "We have envisioned a project of over $400 mi...
...ergy bathing scheme for its population in the coun...ut of China's 800 million rural people bathe only ...thing scheme aimed at introducing China's rural po...ot bath. Tens of millions of Chinese population w...
Other Medicine News:Health News:Rheumatoid Arthritis Averted in Mice by Alcohol Intake 2Health News:Poverty Fuels HIV In Poor Indian States 2
(Date:5/8/2008)...ormulation May Provide New Option for Clinicians C...n Using an Oral NSAID, TAMPA, Fla., May 8 /PRNews...leading global specialty pharmaceutical company, a...is week at the American Pain Society annual,meetin...ive pharmacokinetic,profile of Alpharma Pharmaceut...
(Date:5/7/2008)...ional Study to Evaluate Efficacy and Safety in Tre... Blindness, LEVERKUSEN, Germany, MONTVILLE, New J...irstCall/ -- Bayer HealthCare AG and Regeneron,Pha...d that the first patient,has been dosed in the VIE...velopment program evaluating VEGF Trap-Eye for the...
(Date:5/7/2008)...IEGO, May 7 /- Arena Pharma...hat Taisho Pharmaceutical Co., Ltd.,initiated a Ph...PCR-focused,partnership with Arena to develop comp...didate is a novel oral compound intended for the t...re very happy to see our long-standing partner, Ta...
(Date:5/7/2008)... study shows how sounds are amplified in the inner...s can result from genetic mutation or,overdose of ...wire/ -- St. Jude Children,s,Research Hospital inv...,amplification mechanism in the cochlea of the ear...her mammals. The findings will enable better,under...
Breaking Medicine Technology:Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 2Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 4Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 5Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 6Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 7Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 2Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 3Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 4Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 5Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 6Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 2Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 3St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 2St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 3Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 1Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 2Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 3Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 4Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 5Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 6Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 136 7Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products 184 1Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products 184 2Smoking increases risks for head and neck cancers for men and women 189 1When is a stem cell not really a stem cell 3F 151 1When is a stem cell not really a stem cell 3F 151 2
...udy of over 7,700 women published today shows redu...ent in hip fractures, EAST HANOVER, N.J., May 02, ...clast(R) (zoledronic acid) Injection significantly...c bone fractures,over three years in women with po...oday in The New England Journal of Medicine,marks...
...TON, May 03, 2007 /PRNewswire/ -- Bayer HealthCare...ree clinical,studies with Betaseron(R) (interferon...demy of Neurology,s (AAN) 59th Annual Meeting,dem... and high,patient satisfaction with treatment in p... (MS). , "Collectively, these studies highlight th...
Other Medicine Technology:Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 2Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 3Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 4Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 6Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4
Heavy duty, all purpose illuminator available in black only. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentrated l
A child-friendly vision test that's automatic, objective, and takes just seconds. Welch Allyn created Suresight™, the first objective, accurate vision test that ensures reliable early detection
Portable video magnifier. This powerful new portable unit offers maximum flexibility and control. Includes a wider range of magnification settings, adjustable brightness, and even a tilted screen to
The Clarity Deskmate system offers a high-quality mobile video magnification solution. Deskmate combines Claritys Flex video magnifier with a 15 monitor for excellent visibility. Deskmates rotating c
Medicine Products: